Merck’s poultry deworming product authorised for EU use

Merck Animal Health (also known as MSD Animal Health) has been granted the marketing authorization for the veterinary medicinal product Panacur AquaSol (fenbendazole 200 mg/mL) for use in chickens.

Panacur AquaSol is a highly stable, farm-friendly, water-administered suspension product produced with an innovative wet-milling technology. It is currently available in the EEA for use in swine.

“We are very pleased that the European Commission has approved Panacur AquaSol for chickens,” stated Fabio Paganini, associate vice president, Merck Animal Health. “Panacur has a long history of proven results as a dewormer and we are excited to bring this option for convenient water administration to chicken farmers throughout the EEA.”

Panacur AquaSol will be indicated for the treatment of gastro-intestinal nematodes in chickens infected with:

Ascaridia galli (L5 and adult stages)
Heterakis gallinarum (L5 and adult stages)

Through the company’s proprietary wet-milling technology, Panacur AquaSol is a highly stable suspension which, as a result of smaller more uniform particle size, does not require frequent agitation and provides both a high level of efficacy and convenience.

Panacur AquaSol has been proven safe for all types of chickens, including layers, broilers and breeders. It has a zero day withdrawal period for eggs and a six day withdrawal period for meat and offal.

“Managing intestinal health properly results in better, overall performance for layers, broilers and breeders alike,” explains Rik Koopman, director, scientific affairs, Merck Animal Health. “If not managed with proper parasite control, farmers could experience an economic impact when there is a drop in production or a loss due to worm infestation.”